Collected Dataset / ICoVVaC_CohortB_3months_postdose2

ICoVVaC_CohortB_3months_postdose2
  1. Home
  2. Collected Datasets
  3. ICoVVaC_CohortB_3months_postdose2

ICoVVaC_CohortB_3months_postdose2

Networks -
Variables -
Associated study ICoVVaC Contingency Table

Population

ICoVVaC - Cohort B
The population is composed of cancer patients with solid tumours from cancer clinics at the Ottawa Hospital and at Vancouver BC Cancer, who were not on chemotherapy and who are going to receive COVID-19 vaccination as part of the national vaccine roll-out (standard of care) and included in the study within 4 weeks of the second dose of vaccine.
More info

Data Collection Event

ICoVVaC - Cohort B - 3 months post-dose 2
Information on assessment of clinical outcomes (incidence of COVID-19) and patient self-reported COVID-19 testing results was collected. Blood (serum and peripheral blood mononuclear cells (PBMCs) samples were collected.
More info